BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33687706)

  • 21. DIGE Analysis of ProteoMiner™ Fractionated Serum/Plasma Samples.
    Murphy S; Dowling P
    Methods Mol Biol; 2023; 2596():119-125. PubMed ID: 36378436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune capture and protein profiling of small extracellular vesicles from human plasma.
    Skoczylas Ł; Gawin M; Fochtman D; Widłak P; Whiteside TL; Pietrowska M
    Proteomics; 2024 Jun; 24(11):e2300180. PubMed ID: 37713108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Best practice of identification and proteomic analysis of extracellular vesicles in human health and disease.
    Sódar BW; Kovács Á; Visnovitz T; Pállinger É; Vékey K; Pocsfalvi G; Turiák L; Buzás EI
    Expert Rev Proteomics; 2017 Dec; 14(12):1073-1090. PubMed ID: 29025360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SWATH-MS Protocols in Human Diseases.
    Chantada-Vázquez MDP; García Vence M; Serna A; Núñez C; Bravo SB
    Methods Mol Biol; 2021; 2259():105-141. PubMed ID: 33687711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State of the art of 2D DIGE.
    Arentz G; Weiland F; Oehler MK; Hoffmann P
    Proteomics Clin Appl; 2015 Apr; 9(3-4):277-88. PubMed ID: 25400138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary proteome profiling using 2D-DIGE and LC-MS/MS.
    Weeks ME
    Methods Mol Biol; 2010; 658():293-309. PubMed ID: 20839112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analysis of plasma extracellular vesicles reveals mitochondrial stress upon HTLV-1 infection.
    Jeannin P; Chaze T; Giai Gianetto Q; Matondo M; Gout O; Gessain A; Afonso PV
    Sci Rep; 2018 Mar; 8(1):5170. PubMed ID: 29581472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Testis Tissue Proteomics Using 2-Dye Versus 3-Dye DIGE Analysis.
    Holland A
    Methods Mol Biol; 2018; 1664():185-202. PubMed ID: 29019134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular vesicles in the transfusion medicine field: The potential of proteomics.
    Hermida-Nogueira L; García Á
    Proteomics; 2021 Jul; 21(13-14):e2000089. PubMed ID: 33754471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Extracellular Vesicles Proteomics to Cardiovascular Disease: Guidelines, Data Analysis, and Future Perspectives.
    Barrachina MN; Calderón-Cruz B; Fernandez-Rocca L; García Á
    Proteomics; 2019 Jan; 19(1-2):e1800247. PubMed ID: 30467982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative proteomics of plasma vesicles identify novel biomarkers for hemoglobin E/β-thalassemic patients.
    Kittivorapart J; Crew VK; Wilson MC; Heesom KJ; Siritanaratkul N; Toye AM
    Blood Adv; 2018 Jan; 2(2):95-104. PubMed ID: 29365317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Proteomic Analysis of Extracellular Vesicles Isolated by Acoustic Trapping or Differential Centrifugation.
    Rezeli M; Gidlöf O; Evander M; Bryl-Górecka P; Sathanoori R; Gilje P; Pawłowski K; Horvatovich P; Erlinge D; Marko-Varga G; Laurell T
    Anal Chem; 2016 Sep; 88(17):8577-86. PubMed ID: 27487081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capillary zone electrophoresis of bacterial extracellular vesicles: A proof of concept.
    Piotrowska M; Ciura K; Zalewska M; Dawid M; Correia B; Sawicka P; Lewczuk B; Kasprzyk J; Sola L; Piekoszewski W; Wielgomas B; Waleron K; Dziomba S
    J Chromatogr A; 2020 Jun; 1621():461047. PubMed ID: 32197757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous Enrichment of Plasma Extracellular Vesicles and Glycoproteome for Studying Disease Biomarkers.
    Adav SS; Sze SK
    Methods Mol Biol; 2017; 1619():193-201. PubMed ID: 28674887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-Dimensional Difference Gel Electrophoresis: A Gel-Based Proteomic Approach for Protein Analysis.
    Gao W
    Methods Mol Biol; 2020; 2102():163-176. PubMed ID: 31989554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry.
    Luque-Garcia JL; Neubert TA
    J Chromatogr A; 2007 Jun; 1153(1-2):259-76. PubMed ID: 17166507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
    Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
    Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma.
    Hoffman SA; Joo WA; Echan LA; Speicher DW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):43-52. PubMed ID: 17140865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted and Untargeted Proteomics Approaches in Biomarker Development.
    Sobsey CA; Ibrahim S; Richard VR; Gaspar V; Mitsa G; Lacasse V; Zahedi RP; Batist G; Borchers CH
    Proteomics; 2020 May; 20(9):e1900029. PubMed ID: 31729135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
    Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.